Global Automated Cell Culture market [2017-2027] Europe by End User

Growth Outlook

• The 2027] Europe by End User portion of the Global Automated Cell Culture market [2017 market is on a steady long-term growth path. Segment value stands at roughly USD 4562 Mn in 2026 and is projected to reach USD 4867 Mn by 2027 — a gain of about 7% over the forecast period, translating to a CAGR in the mid-single digits.
• pharmaceutical and biotechnology companies segment accounted for the largest market share in 2019, this market is expected to reach USD 1921. 50 Million in 2027 from USD 999.
• What the regional split looks like (2026): Pharmaceutical & Biotechnology Companies leads, holding roughly 39% of segment value — the single largest regional share. Research Institutes is the second-largest contributor. Hospitals and Diagnostic Laboratories and Cell Banks make up the remainder, in descending order.
• By 2027, Pharmaceutical & Biotechnology Companies alone is expected to reach USD 1922 Mn, with Research Institutes at USD 1559 Mn.

Market Dynamics

pharmaceutical and biotechnology companies segment accounted for the largest market share in 2019, this market is expected to reach USD 1921.50 Million in 2027 from USD 999.20 Million in 2019. This market is projected to grow at a CAGR of 8.39% during the forecast period from 2020 - 2027. However, pharmaceutical and biotechnology companies segment is the fastest growing market, which is expected to grow at a CAGR of 8.39% during the forecast period 2020 - 2027.

Research Methodology

Figures reflect Wantstats’ original market research and forecasting models, compiled as part of the Wantstats research archive and published in 2023.